| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.06e-06 | 15 | 108 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | 2.87e-04 | 5 | 108 | 2 | GO:0099530 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 2.87e-04 | 5 | 108 | 2 | GO:0140955 | |
| GeneOntologyBiologicalProcess | female meiosis II | 1.06e-08 | 6 | 108 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.06e-08 | 6 | 108 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.06e-08 | 6 | 108 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 1.24e-07 | 45 | 108 | 6 | GO:0040020 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 2.16e-07 | 26 | 108 | 5 | GO:0045836 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 3.00e-07 | 52 | 108 | 6 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 1.37e-06 | 37 | 108 | 5 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 4.54e-06 | 82 | 108 | 6 | GO:0051445 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 4.62e-06 | 47 | 108 | 5 | GO:0001556 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 6.85e-06 | 88 | 108 | 6 | GO:0043489 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.52e-05 | 101 | 108 | 6 | GO:1902369 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.53e-05 | 29 | 108 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.01e-05 | 31 | 108 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 3.41e-05 | 172 | 108 | 7 | GO:0051783 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 4.62e-05 | 75 | 108 | 5 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 5.25e-05 | 77 | 108 | 5 | GO:0048255 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 9.42e-05 | 87 | 108 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell differentiation | 1.62e-04 | 4 | 108 | 2 | GO:2000741 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.73e-04 | 99 | 108 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | female gamete generation | 1.74e-04 | 223 | 108 | 7 | GO:0007292 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 2.09e-04 | 103 | 108 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | cartilage condensation | 2.29e-04 | 23 | 108 | 3 | GO:0001502 | |
| GeneOntologyBiologicalProcess | spinal cord oligodendrocyte cell differentiation | 2.69e-04 | 5 | 108 | 2 | GO:0021529 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 2.72e-04 | 240 | 108 | 7 | GO:0140013 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 3.48e-04 | 115 | 108 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | cell aggregation | 3.73e-04 | 27 | 108 | 3 | GO:0098743 | |
| GeneOntologyBiologicalProcess | skeletal system development | 3.82e-04 | 615 | 108 | 11 | GO:0001501 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 3.92e-04 | 118 | 108 | 5 | GO:2000243 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization | 4.72e-04 | 263 | 108 | 7 | GO:1903828 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 5.28e-04 | 268 | 108 | 7 | GO:1903046 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.70e-05 | 155 | 109 | 7 | GO:0098685 | |
| MousePheno | absent ovarian follicles | 1.84e-05 | 51 | 90 | 5 | MP:0002777 | |
| Domain | POLO_box_2 | 1.01e-04 | 3 | 109 | 2 | IPR033695 | |
| Domain | ZM | 1.01e-04 | 3 | 109 | 2 | SM00735 | |
| Domain | BMP_1/tolloid-like | 1.01e-04 | 3 | 109 | 2 | IPR015446 | |
| Domain | Zasp-like_motif | 1.01e-04 | 3 | 109 | 2 | IPR006643 | |
| Domain | - | 2.01e-04 | 4 | 109 | 2 | 3.30.1120.30 | |
| Domain | POLO_box | 2.01e-04 | 4 | 109 | 2 | PF00659 | |
| Domain | POLO_box_1 | 2.01e-04 | 4 | 109 | 2 | IPR033701 | |
| Domain | POLO_BOX | 2.01e-04 | 4 | 109 | 2 | PS50078 | |
| Domain | HMG_box | 2.58e-04 | 53 | 109 | 4 | PF00505 | |
| Domain | HMG_BOX_2 | 2.77e-04 | 54 | 109 | 4 | PS50118 | |
| Domain | HMG | 2.77e-04 | 54 | 109 | 4 | SM00398 | |
| Domain | - | 2.98e-04 | 55 | 109 | 4 | 1.10.30.10 | |
| Domain | POLO_box_dom | 3.34e-04 | 5 | 109 | 2 | IPR000959 | |
| Domain | DUF4749 | 4.99e-04 | 6 | 109 | 2 | PF15936 | |
| Domain | Peptidase_M12A | 4.99e-04 | 6 | 109 | 2 | IPR001506 | |
| Domain | Astacin | 4.99e-04 | 6 | 109 | 2 | PF01400 | |
| Domain | DUF4749 | 4.99e-04 | 6 | 109 | 2 | IPR031847 | |
| Domain | CRAL_TRIO | 5.11e-04 | 27 | 109 | 3 | PS50191 | |
| Domain | HMG_box_dom | 5.65e-04 | 65 | 109 | 4 | IPR009071 | |
| Domain | CRAL-TRIO_dom | 5.70e-04 | 28 | 109 | 3 | IPR001251 | |
| Domain | SPEC | 8.48e-04 | 32 | 109 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 8.48e-04 | 32 | 109 | 3 | IPR018159 | |
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 7670487 | ||
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 11694340 | ||
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 9321470 | ||
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 9.83e-11 | 4 | 111 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 9.83e-11 | 4 | 111 | 4 | 11688365 | |
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 9.83e-11 | 4 | 111 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 9.83e-11 | 4 | 111 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 9.83e-11 | 4 | 111 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 9.83e-11 | 4 | 111 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 9.83e-11 | 4 | 111 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 9.83e-11 | 4 | 111 | 4 | 16963411 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 23579190 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 4.90e-10 | 5 | 111 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 4.90e-10 | 5 | 111 | 4 | 17416365 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 22293198 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 4.90e-10 | 5 | 111 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 4.90e-10 | 5 | 111 | 4 | 8968756 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 4.90e-10 | 5 | 111 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 4.90e-10 | 5 | 111 | 4 | 26411291 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 4.90e-10 | 5 | 111 | 4 | 14648873 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 8896558 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 4.90e-10 | 5 | 111 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 4.90e-10 | 5 | 111 | 4 | 9288969 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 4.90e-10 | 5 | 111 | 4 | 10903443 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 4.90e-10 | 5 | 111 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 4.90e-10 | 5 | 111 | 4 | 8845845 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 4.90e-10 | 5 | 111 | 4 | 19783541 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 17761180 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 4.90e-10 | 5 | 111 | 4 | 12200456 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 11514340 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 4.90e-10 | 5 | 111 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 4.90e-10 | 5 | 111 | 4 | 23223451 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 11804965 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 21270429 | ||
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 8661148 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 1.47e-09 | 6 | 111 | 4 | 18452650 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 1.47e-09 | 6 | 111 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.47e-09 | 6 | 111 | 4 | 31355046 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 20157580 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.47e-09 | 6 | 111 | 4 | 26077710 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 17526644 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 1.47e-09 | 6 | 111 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.47e-09 | 6 | 111 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 1.47e-09 | 6 | 111 | 4 | 23417416 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 32170089 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 16278232 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.47e-09 | 6 | 111 | 4 | 16001084 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 1.47e-09 | 6 | 111 | 4 | 1869307 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 11390979 | ||
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 27632217 | ||
| Pubmed | 2.51e-09 | 18 | 111 | 5 | 22448252 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 15081113 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 22699423 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 3.41e-09 | 7 | 111 | 4 | 16946704 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 10857750 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 3.41e-09 | 7 | 111 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 3.41e-09 | 7 | 111 | 4 | 26826184 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 6.81e-09 | 8 | 111 | 4 | 23204224 | |
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 29883445 | ||
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 10823932 | ||
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 11869379 | ||
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 6.81e-09 | 8 | 111 | 4 | 32339196 | |
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 33749946 | ||
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 22621333 | ||
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.22e-08 | 9 | 111 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.22e-08 | 9 | 111 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.22e-08 | 9 | 111 | 4 | 19695304 | |
| Pubmed | 1.22e-08 | 9 | 111 | 4 | 28235998 | ||
| Pubmed | 1.22e-08 | 9 | 111 | 4 | 20159962 | ||
| Pubmed | A G-quadruplex DNA structure resolvase, RHAU, is essential for spermatogonia differentiation. | 1.53e-08 | 25 | 111 | 5 | 25611385 | |
| Pubmed | 2.03e-08 | 10 | 111 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 2.03e-08 | 10 | 111 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 2.03e-08 | 10 | 111 | 4 | 38433229 | |
| Pubmed | 2.03e-08 | 10 | 111 | 4 | 23810942 | ||
| Pubmed | 2.03e-08 | 10 | 111 | 4 | 12837688 | ||
| Pubmed | 2.03e-08 | 10 | 111 | 4 | 10601091 | ||
| Pubmed | 2.03e-08 | 10 | 111 | 4 | 9922113 | ||
| Pubmed | High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. | 3.16e-08 | 3 | 111 | 3 | 11870237 | |
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 3.19e-08 | 11 | 111 | 4 | 34401671 | |
| Cytoband | Yq11.223 | 8.01e-05 | 93 | 111 | 4 | Yq11.223 | |
| Cytoband | Xq27 | 2.57e-04 | 10 | 111 | 2 | Xq27 | |
| GeneFamily | SRY-boxes | 6.33e-05 | 19 | 75 | 3 | 757 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 2.52e-04 | 6 | 75 | 2 | 894 | |
| GeneFamily | ATPase phospholipid transporting | 1.72e-03 | 15 | 75 | 2 | 1210 | |
| GeneFamily | Cathepsins | 1.72e-03 | 15 | 75 | 2 | 470 | |
| GeneFamily | RNA binding motif containing | 1.92e-03 | 213 | 75 | 5 | 725 | |
| GeneFamily | Heat shock 70kDa proteins | 2.22e-03 | 17 | 75 | 2 | 583 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.60e-03 | 66 | 75 | 3 | 722 | |
| GeneFamily | PDZ domain containing | 3.67e-03 | 152 | 75 | 4 | 1220 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.47e-07 | 12 | 111 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 1.47e-07 | 12 | 111 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 2.53e-06 | 23 | 111 | 4 | MM1293 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SESTD1 SP100 PLK2 SRD5A3 MYO9B CNMD LAMA2 RENBP KLC4 ATP8B2 ITPR3 SLC5A4 NOL4L FBN1 CD36 CTSK FAM83A CYBA | 4.65e-06 | 1242 | 111 | 18 | M1920 |
| Coexpression | MATZUK_SPERMATOGONIA | 8.78e-06 | 31 | 111 | 4 | MM765 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SESTD1 SP100 PLK2 SRD5A3 MYO9B CNMD LAMA2 RENBP KLC4 ATP8B2 ITPR3 SLC5A4 NOL4L FBN1 CD36 CTSK FAM83A CYBA | 1.03e-05 | 1316 | 111 | 18 | MM1052 |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.13e-05 | 33 | 111 | 4 | MM701 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_200 | 6.33e-06 | 51 | 109 | 5 | gudmap_kidney_adult_RenMedVasc_Tie2_k3_200 | |
| CoexpressionAtlas | placenta | 1.28e-05 | 349 | 109 | 10 | placenta | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_100 | 5.21e-05 | 40 | 109 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_100 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-08 | 197 | 111 | 8 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 4.85e-07 | 189 | 111 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-07 | 189 | 111 | 7 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-07 | 194 | 111 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-07 | 194 | 111 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-07 | 194 | 111 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-07 | 194 | 111 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-07 | 195 | 111 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-07 | 195 | 111 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-07 | 195 | 111 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-07 | 195 | 111 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-07 | 195 | 111 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-07 | 195 | 111 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 196 | 111 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 196 | 111 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 196 | 111 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 196 | 111 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 196 | 111 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-07 | 197 | 111 | 7 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-07 | 198 | 111 | 7 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.09e-07 | 200 | 111 | 7 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 168 | 111 | 6 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 180 | 111 | 6 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-06 | 181 | 111 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-06 | 185 | 111 | 6 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 188 | 111 | 6 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 188 | 111 | 6 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.97e-06 | 189 | 111 | 6 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 189 | 111 | 6 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.21e-06 | 190 | 111 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-06 | 190 | 111 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-06 | 190 | 111 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 191 | 111 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.46e-06 | 191 | 111 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 192 | 111 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 192 | 111 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.98e-06 | 193 | 111 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.25e-06 | 194 | 111 | 6 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | droplet-Lung-LUNG-1m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-06 | 194 | 111 | 6 | 621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9 | |
| ToppCell | droplet-Lung-1m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.25e-06 | 194 | 111 | 6 | d16ab5f0cfe73afe6c551fd3123d14784a082f56 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-06 | 195 | 111 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.52e-06 | 195 | 111 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-06 | 195 | 111 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 9.52e-06 | 195 | 111 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-06 | 195 | 111 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 196 | 111 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 196 | 111 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 196 | 111 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 196 | 111 | 6 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 196 | 111 | 6 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 111 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 111 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 111 | 6 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 111 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 111 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.04e-05 | 198 | 111 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 111 | 6 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.04e-05 | 198 | 111 | 6 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 111 | 6 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.04e-05 | 198 | 111 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 111 | 6 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 200 | 111 | 6 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 200 | 111 | 6 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | IIH-CD4-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.48e-05 | 148 | 111 | 5 | ec626a44cea83f2a0e5c27fc8182f96446d297ac | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 3.96e-05 | 152 | 111 | 5 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 156 | 111 | 5 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 156 | 111 | 5 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.36e-05 | 162 | 111 | 5 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.36e-05 | 162 | 111 | 5 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-05 | 162 | 111 | 5 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.52e-05 | 163 | 111 | 5 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-05 | 163 | 111 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.19e-05 | 167 | 111 | 5 | e242827999caad08b0894d88ab97bc1df41b7650 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 169 | 111 | 5 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.73e-05 | 170 | 111 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.12e-05 | 172 | 111 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-05 | 172 | 111 | 5 | fb8ab2576b5c38db63573a3bf46b8d9d634c4999 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 173 | 111 | 5 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.72e-05 | 175 | 111 | 5 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-05 | 176 | 111 | 5 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-05 | 176 | 111 | 5 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-05 | 177 | 111 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-05 | 177 | 111 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 8.15e-05 | 177 | 111 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.15e-05 | 177 | 111 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| Drug | boron trichloride | 7.68e-09 | 6 | 110 | 4 | CID000025135 | |
| Drug | d-gluconhydroximo-1,5-lactam | 3.69e-07 | 31 | 110 | 5 | CID000003479 | |
| Drug | desmethylazelastine | 8.98e-07 | 16 | 110 | 4 | CID000162558 | |
| Drug | dazmegrel | 1.89e-06 | 19 | 110 | 4 | CID000053555 | |
| Drug | YM 026 | 1.89e-06 | 19 | 110 | 4 | CID000004443 | |
| Drug | AZFd | 4.25e-06 | 23 | 110 | 4 | CID000196489 | |
| Drug | dansylaziridine | 4.25e-06 | 23 | 110 | 4 | CID000104008 | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 5.66e-06 | 199 | 110 | 8 | 3205_UP | |
| Drug | bipy | 7.67e-06 | 97 | 110 | 6 | CID000001474 | |
| Drug | kt S | 1.70e-05 | 66 | 110 | 5 | CID006399216 | |
| Drug | Vistar | 2.70e-05 | 36 | 110 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 2.70e-05 | 36 | 110 | 4 | CID000001649 | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 3.64e-05 | 188 | 110 | 7 | 5958_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 3.64e-05 | 188 | 110 | 7 | 6195_DN | |
| Drug | dmid | 3.84e-05 | 14 | 110 | 3 | CID000151469 | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 4.16e-05 | 192 | 110 | 7 | 2831_UP | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 4.30e-05 | 193 | 110 | 7 | 6400_DN | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 4.30e-05 | 193 | 110 | 7 | 6427_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.44e-05 | 194 | 110 | 7 | 5303_UP | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 5825_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 3408_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; PC3; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 5791_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 4754_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 6867_DN | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; MCF7; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 5963_UP | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 3163_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 6444_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 3202_UP | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 4076_DN | |
| Drug | molybdenum disulfide | 5.50e-05 | 43 | 110 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 5.50e-05 | 43 | 110 | 4 | CID000072194 | |
| Drug | propham | 6.03e-05 | 44 | 110 | 4 | CID000024685 | |
| Disease | Male sterility due to Y-chromosome deletions | 1.27e-08 | 8 | 110 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.27e-08 | 8 | 110 | 4 | C1507149 | |
| Disease | heart disease (implicated_via_orthology) | 1.22e-05 | 38 | 110 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | Shprintzen-Goldberg syndrome | 1.38e-05 | 2 | 110 | 2 | C1321551 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.72e-05 | 16 | 110 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.72e-05 | 16 | 110 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.72e-05 | 16 | 110 | 3 | 415000 | |
| Disease | Ventricular Dysfunction | 3.80e-04 | 8 | 110 | 2 | C0242973 | |
| Disease | multisite chronic pain | 4.48e-04 | 95 | 110 | 4 | EFO_0010100 | |
| Disease | Spastic Paraplegia | 4.87e-04 | 9 | 110 | 2 | C0037772 | |
| Disease | Endomyocardial Fibrosis | 4.87e-04 | 9 | 110 | 2 | C0553980 | |
| Disease | Weight Gain | 5.87e-04 | 102 | 110 | 4 | C0043094 | |
| Disease | octadecanedioate measurement | 6.08e-04 | 10 | 110 | 2 | EFO_0021056 | |
| Disease | aortic valve stenosis (is_marker_for) | 7.41e-04 | 11 | 110 | 2 | DOID:1712 (is_marker_for) | |
| Disease | Cardiomyopathy, Dilated | 7.72e-04 | 48 | 110 | 3 | C0007193 | |
| Disease | pain | 8.56e-04 | 196 | 110 | 5 | EFO_0003843 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 8.70e-04 | 50 | 110 | 3 | C1449563 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.27e-03 | 57 | 110 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | myopia (is_implicated_in) | 1.60e-03 | 16 | 110 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | hypertension (biomarker_via_orthology) | 1.64e-03 | 227 | 110 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 1.81e-03 | 17 | 110 | 2 | EFO_0021969 | |
| Disease | dermatomyositis (is_marker_for) | 1.81e-03 | 17 | 110 | 2 | DOID:10223 (is_marker_for) | |
| Disease | body weight | SOX5 STXBP4 ANO5 CHD8 BCKDHB RABGAP1 CPS1 NOL4L DNAH12 TLL1 SLIT1 PLXNA1 | 2.62e-03 | 1261 | 110 | 12 | EFO_0004338 |
| Disease | mean arterial pressure | 2.70e-03 | 499 | 110 | 7 | EFO_0006340 | |
| Disease | Nonsyndromic genetic hearing loss | 2.91e-03 | 76 | 110 | 3 | cv:C5680182 | |
| Disease | Disproportionate short stature | 3.02e-03 | 77 | 110 | 3 | C0878659 | |
| Disease | Nonsyndromic Deafness | 3.48e-03 | 81 | 110 | 3 | C3711374 | |
| Disease | periodontal measurement | 3.60e-03 | 24 | 110 | 2 | EFO_0007780 | |
| Disease | systemic scleroderma (is_implicated_in) | 3.60e-03 | 24 | 110 | 2 | DOID:418 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKAAKCRGYREIPEG | 216 | P43235 | |
| KKIDSCERRFLGGPA | 256 | P08588 | |
| GFEKCRGIIGGKSQR | 2276 | Q9NR48 | |
| CKDSRGRLIPGAYKF | 906 | Q9HCK8 | |
| LSRCPFGIEDGKKRF | 221 | Q75V66 | |
| CAPKKRRTEEKYGGD | 256 | Q8WYQ5 | |
| RDAKAPVLGRFCGSK | 811 | P13497 | |
| IGSCFGRYGSVKEVK | 56 | Q13117 | |
| IGSCFGRYGSVKEVK | 56 | Q9NR90 | |
| RTPSGKLRLYCKGAD | 561 | Q9Y2Q0 | |
| IVRNPEGKIRLYCKG | 566 | P98198 | |
| IKARRLGGRGQSKYC | 146 | P48382 | |
| TGRRNAGEKIKYCLV | 341 | Q14573 | |
| EGCKGFFRRSVIKGA | 116 | Q13133 | |
| GKRGKYKEAEPLCQR | 306 | Q9NSK0 | |
| CTVGLRDKYGKDRVF | 106 | P21953 | |
| RCREFFNKEGRVKGI | 971 | Q9Y3P9 | |
| VGKSPKDRLCRRDVG | 1076 | Q9H2M9 | |
| GKKCAFVLTRDGRPV | 111 | P51606 | |
| FYKGDECLGSGKILR | 371 | O75648 | |
| DKYGPRKLRLLGSAC | 111 | Q8N370 | |
| EKDEFGRRDLVIGKC | 151 | Q9BQP9 | |
| GVFVCLLEYPRGKRK | 46 | P13498 | |
| VKPFFCRIRGGEDRK | 206 | P56645 | |
| IRAKYGGIERENGCL | 1081 | Q9UIW2 | |
| CEGGDLYRKLKEQKG | 86 | P51957 | |
| KVCDGCFGELKKRGR | 1291 | Q6ZNL6 | |
| CFGELKKRGRAVPGL | 1296 | Q6ZNL6 | |
| VSDPEFFKGCRGKEL | 2626 | Q6ZR08 | |
| GGDCIRTYKPEIKKG | 2151 | P24043 | |
| RSVEGEIYCAKSGRK | 221 | Q86UY5 | |
| RNCIIGKGRSYKGTV | 126 | P14210 | |
| CGADGLRSRVKYGVK | 111 | Q96MY1 | |
| REQALCGPGLRKTKY | 356 | Q7Z6J2 | |
| KKRLAGEYGRGDLVG | 631 | Q6ZV29 | |
| VVSEGGKPKVRVCYR | 96 | P48741 | |
| GKPKVRVCYRGEDKT | 101 | P48741 | |
| GDKEKTGVRFLRCPA | 156 | P35227 | |
| VGISRIAKVKYGECG | 516 | Q9NQV7 | |
| FQDLIRYGKTKCGEP | 46 | Q9H8P0 | |
| YRTAGPELGSRRKKC | 556 | Q9HB29 | |
| CFIKRSRGGKYPVRE | 1236 | O94856 | |
| VKKAFRFSAGPGCRR | 116 | P0CG42 | |
| CGVELFKRGVLKEYG | 516 | P31327 | |
| IGSCFGRYGSVKEVK | 56 | Q9NQZ3 | |
| IGSCFGRYGSVKEVK | 221 | Q9NQZ3 | |
| IGSCFGRYGSVKEVK | 386 | Q9NQZ3 | |
| EEARCKSLGRFPNGK | 211 | P20023 | |
| GKGKRLPEVYCIVSR | 656 | Q9ULE3 | |
| EKINFRCKPTFREGG | 226 | O75912 | |
| PKGYILQEDGRSCKD | 2471 | P35555 | |
| GVLDISKCKEGRPVY | 326 | P16671 | |
| GLKGYVAERKGEREE | 106 | Q9H0C8 | |
| IYRGEAVRKGTPECS | 516 | Q96GE4 | |
| KVPVSYCGKRARLGD | 351 | Q9UH90 | |
| KAIVFCKRRVESGEG | 731 | P10911 | |
| CVGDRRERKAAFKGD | 186 | P08311 | |
| IGSCFGRYGSVKEVK | 56 | Q86SG3 | |
| IGSCFGRYGSVKEVK | 221 | Q86SG3 | |
| VVSEGGKPKVRVCYR | 96 | P17066 | |
| GKPKVRVCYRGEDKT | 101 | P17066 | |
| KVPERKCGEIREQYG | 61 | Q13255 | |
| DKCGTGIVGVFVKLR | 261 | O00151 | |
| KSCTKEVGGRQLREG | 416 | Q92833 | |
| KIYKGPLGCSERASI | 2031 | P11717 | |
| FDICGRVGGVRKALK | 346 | Q96EX2 | |
| SCLLGRDKVKEPRAG | 71 | A6NDD5 | |
| ECGGRLKAESKPRDL | 886 | O43897 | |
| DRGEYLGKLVRFCKV | 131 | Q8WXG1 | |
| EPKCVKIGALEGYRG | 111 | O43776 | |
| AEKRLIPDGCGVKYI | 186 | P27635 | |
| AEIRGKPIKSSCLYG | 151 | Q6ZMB5 | |
| RKPEEIRGGGLLKYC | 226 | Q8NEK8 | |
| GVEEDYPEKSRGCLK | 586 | Q9NY91 | |
| GRCKALTGYEPGEKD | 271 | Q8TF17 | |
| KCGSGIVGAVVKARD | 296 | Q53GG5 | |
| EIIPGGDCYKDGRLK | 51 | Q6ZWJ1 | |
| YGDKGTVRQVRESKC | 376 | Q8N1H7 | |
| DKGCEAGRLRAKYSA | 651 | P12755 | |
| LDKFPRDCVKVGGRH | 1046 | Q9Y4F9 | |
| EKCKARGFTVIVDGR | 56 | Q86VW0 | |
| RTCIVDGKKLRIGEY | 696 | P35712 | |
| GTEEYKICRGIKEGR | 721 | P53396 | |
| SPGDYICRKGDIGKE | 476 | Q16280 | |
| TGIRFAGGEKCYIKA | 121 | O75829 | |
| IRGIKKTDEGTYRCE | 176 | P13591 | |
| KLPCLRKRAEGLSGY | 201 | Q6URK8 | |
| KPAARKAFERCSEGV | 421 | P23246 | |
| EKSCLSPGREEKGRL | 271 | Q7M4L6 | |
| CIVEGKRLRVGEYKA | 501 | Q9UN79 | |
| VRVCGTLLEYLGKGK | 226 | Q8NCJ5 | |
| VPEKTLTCGKGRRDF | 236 | Q8TAW3 | |
| VTDYGAFIKIPGCRK | 26 | Q9NP64 | |
| PVTCGEVKGTLYKER | 606 | P23497 | |
| AGKVGELCAGKERRE | 306 | P18206 | |
| KDCFERPRRVGAKFT | 131 | O95391 | |
| ICEEGDGPRRIKRTY | 446 | O60290 | |
| REKPYIGNECGKAFR | 141 | Q6ZN19 | |
| RVKEGYRDGIDAGKA | 41 | Q9NRH1 | |
| GRDSCTRKIGLEKIG | 436 | Q86VQ6 | |
| YVGLTCKGIDRKGEE | 441 | O95361 | |
| RTCLVDGKKLRIGEY | 631 | P35711 | |
| EEGKGGLPAKRCVLR | 186 | P0C1S8 | |
| GEFGTVYKCIKRLDG | 221 | P0C1S8 | |
| PTTGKRYCRGKVLGK | 76 | Q9NYY3 | |
| LRGEKGRYVAVPACE | 31 | Q9UNX4 | |
| RKSCGIAGGDKTERR | 331 | Q6UX68 | |
| LKVGEIGKEGCRPRA | 926 | Q8IWB9 | |
| DGLTGEKAIYKRRGE | 1686 | A3KMH1 | |
| VKTGYKEPGIARCAG | 881 | O75093 | |
| GKLLCFDDEGTPRTK | 96 | Q6IV72 | |
| CKDGEFRRYQGPRTK | 106 | Q9H3N1 | |
| KREGEGKYRAECKLD | 286 | Q96PF2 | |
| PRCDVVERFGKSKDG | 111 | P15621 | |
| EKVAYLSGGRDKRGG | 71 | O75962 | |
| RGLEPKTCFRKIGDS | 406 | Q5H9K5 | |
| VEYDGERKKTLCGTP | 201 | P53350 | |
| GIDVKKGRGRYIDTC | 3381 | Q5THJ4 | |
| VVRGVKFGEYRCEKE | 1371 | Q13402 | |
| YKKRATGREEGLEVG | 416 | Q13459 |